GAM Holding’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

GAM Holding’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,300	Closed	-$280K	–	205
2023 Q2	$280K	Buy	+7,300	New	+$187K	0.02%	186

GAM Holding's KDNY Position: Q3 2023 in Review

GAM Holding sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 7,300 shares — an estimated $280K sold.

GAM Holding first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $280K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

GAM Holding reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
GAM Holding sold 7,300 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $280K.
GAM Holding first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
GAM Holding's Chinook Therapeutics, Inc. Common Stock position peaked at $280K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on GAM Holding's 13F filing for Q3 2023, filed 16 Oct 2023.